508 related articles for article (PubMed ID: 14593181)
1. Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis.
Mallucci G; Dickinson A; Linehan J; Klöhn PC; Brandner S; Collinge J
Science; 2003 Oct; 302(5646):871-4. PubMed ID: 14593181
[TBL] [Abstract][Full Text] [Related]
2. Normal host prion protein necessary for scrapie-induced neurotoxicity.
Brandner S; Isenmann S; Raeber A; Fischer M; Sailer A; Kobayashi Y; Marino S; Weissmann C; Aguzzi A
Nature; 1996 Jan; 379(6563):339-43. PubMed ID: 8552188
[TBL] [Abstract][Full Text] [Related]
3. Prion propagation and toxicity occur in vitro with two-phase kinetics specific to strain and neuronal type.
Hannaoui S; Maatouk L; Privat N; Levavasseur E; Faucheux BA; Haïk S
J Virol; 2013 Mar; 87(5):2535-48. PubMed ID: 23255799
[TBL] [Abstract][Full Text] [Related]
4. Sheep scrapie susceptibility-linked polymorphisms do not modulate the initial binding of cellular to disease-associated prion protein prior to conversion.
Rigter A; Bossers A
J Gen Virol; 2005 Sep; 86(Pt 9):2627-2634. PubMed ID: 16099922
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol transporter ATP-binding cassette A1 (ABCA1) is elevated in prion disease and affects PrPC and PrPSc concentrations in cultured cells.
Kumar R; McClain D; Young R; Carlson GA
J Gen Virol; 2008 Jun; 89(Pt 6):1525-1532. PubMed ID: 18474570
[TBL] [Abstract][Full Text] [Related]
6. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
Moreno JA; Telling GC
Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress and neurodegeneration in prion diseases.
Kim JI; Choi SI; Kim NH; Jin JK; Choi EK; Carp RI; Kim YS
Ann N Y Acad Sci; 2001 Apr; 928():182-6. PubMed ID: 11795509
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human prion protein inhibits prion propagation in vitro.
Yuan J; Zhan YA; Abskharon R; Xiao X; Martinez MC; Zhou X; Kneale G; Mikol J; Lehmann S; Surewicz WK; Castilla J; Steyaert J; Zhang S; Kong Q; Petersen RB; Wohlkonig A; Zou WQ
Sci Rep; 2013 Oct; 3():2911. PubMed ID: 24105336
[TBL] [Abstract][Full Text] [Related]
9. The Ninth Datta Lecture. Molecular biology of transmissible spongiform encephalopathies.
Weissmann C
FEBS Lett; 1996 Jun; 389(1):3-11. PubMed ID: 8682199
[TBL] [Abstract][Full Text] [Related]
10. Intrinsic resistance of oligodendrocytes to prion infection.
Prinz M; Montrasio F; Furukawa H; van der Haar ME; Schwarz P; Rülicke T; Giger OT; Häusler KG; Perez D; Glatzel M; Aguzzi A
J Neurosci; 2004 Jun; 24(26):5974-81. PubMed ID: 15229245
[TBL] [Abstract][Full Text] [Related]
11. Scrapie-specific neuronal lesions are independent of neuronal PrP expression.
Jeffrey M; Goodsir CM; Race RE; Chesebro B
Ann Neurol; 2004 Jun; 55(6):781-92. PubMed ID: 15174012
[TBL] [Abstract][Full Text] [Related]
12. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H
J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329
[TBL] [Abstract][Full Text] [Related]
13. Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death.
Cronier S; Laude H; Peyrin JM
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12271-6. PubMed ID: 15302929
[TBL] [Abstract][Full Text] [Related]
14. Differences in scrapie-induced pathology of the retina and brain in transgenic mice that express hamster prion protein in neurons, astrocytes, or multiple cell types.
Kercher L; Favara C; Chan CC; Race R; Chesebro B
Am J Pathol; 2004 Dec; 165(6):2055-67. PubMed ID: 15579448
[TBL] [Abstract][Full Text] [Related]
15. Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease.
White MD; Farmer M; Mirabile I; Brandner S; Collinge J; Mallucci GR
Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10238-43. PubMed ID: 18632556
[TBL] [Abstract][Full Text] [Related]
16. Update on Creutzfeldt-Jakob disease.
Mallucci G; Collinge J
Curr Opin Neurol; 2004 Dec; 17(6):641-7. PubMed ID: 15542971
[TBL] [Abstract][Full Text] [Related]
17. Effect of intraventricular infusion of anti-prion protein monoclonal antibodies on disease progression in prion-infected mice.
Song CH; Furuoka H; Kim CL; Ogino M; Suzuki A; Hasebe R; Horiuchi M
J Gen Virol; 2008 Jun; 89(Pt 6):1533-1544. PubMed ID: 18474571
[TBL] [Abstract][Full Text] [Related]
18. The N-terminal, polybasic region of PrP(C) dictates the efficiency of prion propagation by binding to PrP(Sc).
Turnbaugh JA; Unterberger U; Saá P; Massignan T; Fluharty BR; Bowman FP; Miller MB; Supattapone S; Biasini E; Harris DA
J Neurosci; 2012 Jun; 32(26):8817-30. PubMed ID: 22745483
[TBL] [Abstract][Full Text] [Related]
19. Human anti-prion antibodies block prion peptide fibril formation and neurotoxicity.
Wei X; Roettger Y; Tan B; He Y; Dodel R; Hampel H; Wei G; Haney J; Gu H; Johnstone BH; Liu J; Farlow MR; Du Y
J Biol Chem; 2012 Apr; 287(16):12858-66. PubMed ID: 22362783
[TBL] [Abstract][Full Text] [Related]
20. Pressure-assisted dissociation and degradation of "proteinase K-resistant" fibrils prepared by seeding with scrapie-infected hamster prion protein.
Akasaka K; Maeno A; Murayama T; Tachibana H; Fujita Y; Yamanaka H; Nishida N; Atarashi R
Prion; 2014; 8(4):314-8. PubMed ID: 25482603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
